metformin tirzepatide Mounjaro and Metformin: A Head-to-Head Comparison Do You Still Need Metformin

The Big Trial of a GLP-1 drug (Wegovy) to Reduce Major Cardiovascular Events Presented at the American Heart Association and simultaneously published in NEJM today is the trial of over 17,600 patients who were randomly assigned either the GLP-1 semaglutide (a glucagon-like peptide-1 receptor agonist) or placebo and were followed for well over 3 years

Understanding these distinctions provides useful context when interpreting Certificates of Analysis and comparing 5-Amino-1MQ with more familiar peptide research compounds

Have you had heart palpitations while taking methotrexate or living with lupus

doi: 10.1186/s13048-023-01227-w 104